ArticleScientific reports2022

Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma.

Shoya Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.